Rybodyn
San Diego
About Rybodyn
Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $14.0M
- Funding stage: Seed
- Last round: Seed (Mar 2026)
- Website: rybodyn.com
Industries & Categories
Biotechnology, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/rybodyn-17623 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.